Covid Benefits: The Italian Billionaire Family Making Glass Vials For Vaccines Scores With U.S. IPO

The 72-year-old firm based in northern Italy debuted on the New York Stock Exchange in a rare public listing for an Italian company, adding $550 million to the Stevanato family’s coffers.

Source: https://www.forbes.com/sites/giacomotognini/2021/07/23/covid-benefits-the-italian-billionaire-family-making-glass-vials-for-vaccines-scores-with-us-ipo/

Join the Discussion

  • BrokerEUR/USD
    ETX Capital 0.6pips (variable) margin: 3.33%
    InterTrader 0.6pips (fixed) margin: 3.33%
  • Back to top